Nihon Kohden (OTCMKTS:NHNKY) Sees Strong Trading Volume – What’s Next?

Shares of Nihon Kohden Corporation (OTCMKTS:NHNKYGet Free Report) saw unusually-strong trading volume on Thursday . Approximately 28,894 shares changed hands during mid-day trading, an increase of 15% from the previous session’s volume of 25,081 shares.The stock last traded at $9.5280 and had previously closed at $9.58.

Analyst Upgrades and Downgrades

Separately, UBS Group lowered Nihon Kohden from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 12th. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Nihon Kohden has a consensus rating of “Hold”.

Read Our Latest Report on Nihon Kohden

Nihon Kohden Trading Up 0.8%

The business’s 50-day simple moving average is $9.48 and its two-hundred day simple moving average is $9.41. The firm has a market cap of $1.60 billion, a price-to-earnings ratio of 17.34 and a beta of 0.36.

Nihon Kohden (OTCMKTS:NHNKYGet Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.06 by ($0.09). The firm had revenue of $297.47 million for the quarter, compared to the consensus estimate of $299.98 million. Nihon Kohden had a net margin of 5.90% and a return on equity of 9.08%. On average, analysts forecast that Nihon Kohden Corporation will post 0.6 earnings per share for the current fiscal year.

About Nihon Kohden

(Get Free Report)

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.

Further Reading

Receive News & Ratings for Nihon Kohden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nihon Kohden and related companies with MarketBeat.com's FREE daily email newsletter.